KKKasper Birch Kristensen

Kasper Birch Kristensen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Kasper Birch Kristensen has a total of 47 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Low‐Dose Glucagon After Fasted Morning Exercise in People With Type 1 Diabetes—A Randomised Crossover Comparison of Low and High Carbohydrate Diets

    by Signe Schmidt, Kasper Birch Kristensen, Olivia Mary McCarthy, Richard Michael Bracken, Jens Juul Holst, Kirsten Nørgaard, Ajenthen Gayathri Ranjan

  • Open Access

    Influence of Diets Differing in Macronutrient Composition on Metabolic Regulation During Exercise in Adults with Type 1 Diabetes

    by Olivia Mary McCarthy, Kasper Birch Kristensen, Ajenthen Gayathri Ranjan, Chloe Nicholas, Jens Juul Holst, Richard Michael Bracken, Kirsten Nørgaard, Signe Schmidt

    Aim: To compare the effect of consuming three isocaloric diets that differed in macronutrient composition on substrate oxidation and glucose regulation during sustained submaximal exercise in adults with type 1 diabetes (T1D). Methods: In a randomised, crossover design, 12 adults with T1D (n = 4 female, age: 46 ± 15 years, HbA1c: 55.9 ± 7.8 mmol/mol) consumed three isocaloric diets over seven days: (i) HCLFLP (high-carbohydrate [48%], low-fat [33%], low-protein [19%]), (ii) LCHFLP (low-carbohydrate [19%]), high-fat [62%], low-protein [19%]), and (iii) LCLFHP (low-carbohydrate (19%), low-fat [57%], high-protein [24%]). On the morning of day eight, participants undertook 45 min of cycling (≈60% V.O2peak) whilst fasting. Venous-derived plasma glucose and free fatty acids (FFA) were measured throughout the trial period. Indirect calorimetry was used to determine rates of substrate oxidation during exercise. Data were analysed via repeated measures ANOVAs with p ≤ 0.05 accepted as significant. Results: During exercise, rates of lipid oxidation were higher (1.2-fold, p = 0.030) and carbohydrate oxidation lower (0.8-fold, p = 0.030) in LCHFLP versus HCLFLP. Concentrations of FFA after exercise were higher in LCHFLP compared to HCLFLP (by ≈22%, p = 0.019). Overall time spent in euglycaemia was higher (HCLFLP: 55.6 ± 43.9, LCHFLP: 87.3 ± 28.7, LCLFHP: 95.2 ± 7.9%, p = 0.003) and hyperglycaemia lower (HCLFLP: 44.4 ± 43.9, LCHFLP: 12.7 ± 28.7, LCLFHP: 4.8 ± 7.9%, p = 0.003) in both LC diets relative to HC. No differences in any measured biomarkers were observed between the two LC diets. Conclusions: One-week consumption of isocaloric diets that differed in their macronutrient composition shifted patterns of energy metabolism during a standardised bout of moderate intensity exercise performed in the fasted state in adults with T1D.


  • Open Access

    Metabolic and Hormonal Responses to Isomaltulose Ingestion Before or During Sustained Submaximal Exercise in Adults with Type 1 Diabetes Using Automated Insulin Delivery Systems

    by Olivia M. McCarthy, Merete Bechmann Christensen, Sandra Tawfik, Kasper Birch Kristensen, Bolette Hartmann, Jens Juul Holst, Signe Schmidt, Kirsten Nørgaard, Richard M. Bracken

    Objectives: This article compares metabolic, pancreatic, and gut-derived hormone responses to isomaltulose ingestion, before versus during submaximal sustained exercise, in adults with type 1 diabetes (T1D) using automated insulin delivery systems. Methods: In a randomized, cross-over trial, eight participants with T1D being treated with automated insulin pumps (five females, age: 47 ± 16 years, BMI: 27.5 ± 3.8 kg·m2, diabetes duration: 23 ± 11 years, HbA1c: 8.3 ± 0.9 [67.5 ± 9.5]% [mmol/mol]) attended the laboratory on two separate occasions and consumed an isocaloric amount of isomaltulose as either (1) a single serving (0.75g CHO·kg−1 BM) with a 25% reduction in bolus insulin 90 min before 45 min of cycling (PEC) or (2) three separate isocaloric servings (0.25g CHO·kg−1 BM each) without bolus insulin during exercise (DEC). Plasma glucose (PG), gut incretins (GLP-1 and GIP), pancreatic glucagon, exogenous insulin, and whole-body fuel oxidation rates were determined. Data were treated via a two-way repeated measures ANOVA, with p ≤ 0.05 accepted as significant. Results: PG concentrations throughout exercise were higher and less variable with DEC compared to PEC. The exercise-induced change in PG was directionally divergent between trials (PEC: ∆ − 3.2 ± 1.2 mmol/L vs. DEC: ∆ + 1.7 ± 1.5 mmol/L, p < 0.001), changing at a rate of −0.07 ± 0.03 mmol/L/min with PEC and +0.04 ± 0.03 mmol/L/min with DEC (p < 0.001 between conditions). Throughout the exercise period, GLP-1, GIP, glucagon, and total insulin concentrations were lower with DEC (all p ≤ 0.02). The oxidation rates of carbohydrates were lower (p = 0.009) and of lipids were greater (p = 0.014) with DEC compared to PEC. Conclusions: The consumption of smaller servings of isomaltulose during, rather than as a single isocaloric serving before, submaximal sustained exercise provided (i) a better glycemic protective effect, (ii) a lesser push on pancreatic and gut-mediated glucoregulatory hormones, and (iii) a lower reliance on whole-body carbohydrate oxidation. Such information serves to remind us of the potential importance of nutrition for modulating the metabolic fate of an acute bout of exercise and may help inform best practice guidelines for exercise management in the T1D-sphere.


  • Open Access

    Sensor-Based Glucose Metrics during Different Diet Compositions in Type 1 Diabetes—A Randomized One-Week Crossover Trial

    by Kasper B. Kristensen, Ajenthen G. Ranjan, Olivia M. McCarthy, Richard M. Bracken, Kirsten Nørgaard, Signe Schmidt

    By reducing carbohydrate intake, people with type 1 diabetes may reduce fluctuations in blood glucose, but the evidence in this area is sparse. The aim of this study was to investigate glucose metrics during a one-week low-carbohydrate-high-fat (HF) and a low-carbohydrate-high-protein (HP) diet compared with an isocaloric high-carbohydrate (HC) diet. In a randomized, three-period cross-over study, twelve adults with insulin-pump-treated type 1 diabetes followed an HC (energy provided by carbohydrate: 48%, fat: 33%, protein: 19%), HF (19%, 62%, 19%), and an HP (19%, 57%, 24%) diet for one week. Glucose values were obtained during intervention periods using a Dexcom G6 continuous glucose monitoring system. Participant characteristics were: 33% females, median (range) age 50 (22–70) years, diabetes duration 25 (11–52) years, HbA1c 7.3 (5.5–8.3)% (57 (37–67) mmol/mol), and BMI 27.3 (21.3–35.9) kg/m2. Glycemic variability was lower with HF (30.5 ± 6.2%) and HP (30.0 ± 5.5%) compared with HC (34.5 ± 4.1%) (PHF-HC = 0.009, PHP-HC = 0.003). There was no difference between groups in mean glucose (HF: 8.7 ± 1.1, HP: 8.2 ± 1.0, HC: 8.7 ± 1.0 mmol/L, POverall = 0.08). Time > 10.0 mmol/L was lower with HP (22.3 ± 11.8%) compared with HF (29.4 ± 12.1%) and HC (29.5 ± 13.4%) (PHF-HP = 0.037, PHC-HP = 0.037). In conclusion, a one-week HF and, specifically, an HP diet improved glucose metrics compared with an isocaloric HC diet.


  • Effects of a Low-Carbohydrate-High-Protein Pre-Exercise Meal in Type 1 Diabetes—a Randomized Crossover Trial

    by Kasper B Kristensen, Ajenthen G Ranjan, Olivia M McCarthy, Jens J Holst, Richard M Bracken, Kirsten Nørgaard, Signe Schmidt

    Context Current guidelines for exercise-related glucose management focus on reducing bolus and/or basal insulin doses and considering carbohydrate intake. Yet far less attention has been paid to the potential role of other macronutrients alongside carbohydrates on glucose dynamics around exercise. Objective To investigate the effects of a low-carbohydrate-high-protein (LCHP) compared to a high-carbohydrate-low-protein (HCLP) pre-exercise meal on the metabolic, hormonal, and physiological responses to exercise in adults with insulin pump-treated type 1 diabetes. Methods Fourteen adults with insulin pump-treated type 1 diabetes (11 females with a median [range] HbA1c of 50 [43-59] mmol/mol (6.7 [6.1-7.5] %), age of 49 [25-65] years, and BMI of 24.0 [19.3-27.1] kg/m2) completed an unblinded, two-arm, randomised, crossover study. Participants ingested isocaloric meals that were either LCHP (carbohydrate 21%, protein 52%, fat 27%) or HCLP (carbohydrate 52%, protein 21%, fat 27%) 90 min prior to undertaking 45 min of cycling at moderate intensity. Meal insulin bolus was dosed according to meal carbohydrate content but reduced by 25%. Basal insulin rates were reduced by 35% from meal ingestion to end of exercise. Results Around exercise the coefficient of variability was lower during LCHP (LCHP:14.5±5.3 vs. HCLP: 24.9±7.7%, p=0.001). Over exercise, LCHP was associated with a lesser drop (LCHP: Δ-1.49±1.89 vs. HCLP: Δ-3.78±1.95 mmol/L, p=0.001). Mean insulin concentration was 30% lower during exercise for LCHP compared to HCLP (LCHP: 25.5±11.0 vs. HCLP: 36.5±15.9 mU/L, p<0.001). Conclusions Ingesting a LCHP pre-exercise meal lowered plasma glucose variability around exercise and diminished the drop in plasma glucose over exercise.


  • Automated Insulin Delivery Around Exercise in Adults with Type 1 Diabetes: A Pilot Randomized Controlled Study

    by Olivia Mary Mccarthy, Merete Bechmann Christensen, Kasper Birch Kristensen, Signe Schmidt, Ajenthen G. Ranjan, Stephen C. Bain, Richard M. Bracken, Kirsten Nørgaard

    Aim: To assess the effectiveness of an automated insulin delivery (AID) system around exercise in adults with type 1 diabetes (T1D). Methods: This was a three-period, randomized, crossover trial involving 10 adults with T1D (hemoglobin A1C; HbA 1c : 8.3% ± 0.6% [67 ± 6 mmol/mol]) using an AID system (MiniMed 780G; Medtronic USA). Participants performed 45 min of moderate intensity continuous exercise 90 min after consuming a carbohydrate-based meal using three strategies: (1) a 100% dose of bolus insulin with exercise announcement immediately at exercise onset “spontaneous exercise” (SE) or a 25% reduced dose of bolus insulin with exercise announcement either (2) 90 min (AE90) or (3) 45 min (AE45) before exercise. Venous-derived plasma glucose (PG) taken in 5 and 15 min intervals over a 3 h collection period was stratified into the percentage of time spent below (TBR [ 10 mmol/L]). In instances of hypoglycemia, PG data were carried forward for the remainder of the visit. Results: Overall, TBR was greatest during SE (SE: 22.9 ± 22.2, AE90: 1.1 ± 1.9, AE45: 7.8% ± 10.3%, P = 0.029). Hypoglycemia during exercise occurred in four participants in SE but one in both AE90 and AE45 ( ꭓ 2 [2] = 3.600, P = 0.165). In the 1 h postexercise period, AE90 was associated with higher TIR (SE: 43.8 ± 49.6, AE90: 97.9 ± 5.9, AE45: 66.7% ± 34.5%, P = 0.033), lower TBR (SE: 56.3 ± 49.6, AE90: 2.1 ± 5.9, AE45: 29.2% ± 36.5%, P = 0.041) with the greatest source of discrepancy observed relative to SE. Conclusion: In adults using an AID system and undertaking postprandial exercise, a strategy involving both bolus insulin dose reduction and exercise announcement 90 min before commencing the activity may be most effective in minimizing dysglycemia. The study was registered as a clinical trial (Clinical Trials Register; NCT05134025)


  • GLP−1 Promotes Cortical and Medullary Perfusion in the Human Kidney and Maintains Renal Oxygenation During NaCl Loading

    by Bryan Haddock, Kasper B. Kristensen, Mahvish Tayyab, Henrik B. W. Larsson, Ulrich Lindberg, Mark Vestergaard, Susan Francis, Boye L. Jensen, Ulrik B. Andersen, Ali Asmar

    Background: GLP‐1 (glucagon‐like peptide‐1) receptor agonists exert beneficial long‐term effects on cardiovascular and renal outcomes. In humans, the natriuretic effect of GLP‐1 depends on GLP‐1 receptor interaction, is accompanied by suppression of angiotensin II, and is independent of changes in renal plasma flow. In rodents, angiotensin II constricts vasa recta and lowers medullary perfusion. The current randomized, controlled, crossover study was designed to test the hypothesis that GLP‐1 increases renal medullary perfusion in healthy humans. Methods and Results: Healthy male participants (n=10, aged 27±4 years) ingested a fixed sodium intake for 4 days and were examined twice during a 1‐hour infusion of either GLP‐1 (1.5 pmol/kg per minute) or placebo together with infusion of 0.9% NaCl (750 mL/h). Interleaved measurements of renal arterial blood flow, oxygenation (R 2 *), and perfusion were acquired in the renal cortex and medulla during infusions, using magnetic resonance imaging. GLP‐1 infusion increased medullary perfusion (32±7%, P P P =0.007), whereas cortical perfusion remained unchanged. R 2 * values increased by 3±2% ( P =0.025) in the medulla and 4±1% ( P =0.008) in the cortex during placebo, indicative of decreased oxygenation, but remained unchanged during GLP‐1. Blood flow in the renal artery was not altered significantly by either intervention. Conclusions: GLP‐1 increases predominantly medullary but also cortical perfusion in the healthy human kidney and maintains renal oxygenation during NaCl loading. In perspective, suppression of angiotensin II by GLP‐1 may account for the increase in regional perfusion. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT04337268.


  • Influence of exercise amount and intensity on long-term weight loss maintenance and skeletal muscle mitochondrial ROS production in humans

    by Steen Larsen, Sune Dandanell, Kasper Birch Kristensen, Sofie Drevsholt Jørgensen, Flemming Dela, Jørn Wulff Helge

    Sustaining a weight loss after a lifestyle intervention is challenging. The objective of the present study was to investigate if mitochondrial function is associated with the ability to maintain a weight loss. Sixty-eight former participants in an 11–12-week lifestyle intervention were recruited into 2 groups; weight loss maintenance (WLM; body mass index (BMI): 32 ± 1 kg/m2) and weight regain (WR; BMI: 43 ± 2 kg/m2) based on weight loss measured at a follow-up visit (WLM: 4.8 ± 0.4; WR: 7.6 ± 0.8 years after lifestyle intervention). Maximal oxygen consumption rate, physical activity level, and blood and muscle samples were obtained at the follow-up experiment. Mitochondrial respiratory capacity and reactive oxygen species (ROS) production were measured. Fasting blood samples were used to calculate glucose homeostasis index. WR had impaired glucose homeostasis and decreased maximal oxygen uptake and physical activity level compared with WLM. The decreased physical activity in WR was due to a lower activity level at vigorous and moderate intensities. Mitochondrial respiratory capacity and citrate synthase (CS) activity was higher in WLM, but intrinsic mitochondrial respiratory capacity (mitochondrial respiratory capacity corrected for mitochondrial content (CS activity)) was similar. ROS production was higher in WR compared with WLM, which was accompanied by a decreased content of antioxidant proteins in WR. Intrinsic mitochondrial respiratory capacity in skeletal muscle is not associated with the ability to maintain a long-term weight loss. WLM had a higher maximal oxygen uptake, physical activity level, mitochondrial respiratory capacity and CS activity compared with WR. The reduced glucose tolerance was concurrent with increased ROS production per mitochondria in WR, and could also be associated with the lower physical activity level in this group.


  • Open Access

    Study of correlation between the NAT2 phenotype and genotype status among Greenlandic Inuit

    by Emilie Birch Kristensen, Victor Yakimov, Karen Bjorn-Mortensen, Bolette Soborg, Anders Koch, Mikael Andersson, Kasper Birch Kristensen, Sascha Wilk Michelsen, Line Skotte, Anne Ahrendt Bjerregaard, et al.

    N-acetyltransferase 2 (NAT2) is the main enzyme metabolizing isoniazid and genotype-based treatment has been studied for years without becoming common practice. To investigate whether genotype-based isoniazid treatment is feasible in Greenland, we sequenced the coding sequence of NAT2 and determined the NAT2 enzyme-activity by caffeine test. No additional genetic variants were identified in the coding sequence of NAT2, so that genotype status in 260 study participants could be assessed by a well-established 7-SNP panel. Studying the enzyme activity by the ratio of the two caffeine metabolites AFMU and 1X in 260 participants showed a high rate of slow phenotypes with intermediate or rapid genotype. These misclassifications were mainly observed in urine samples with pH3, we observed a moderate level of discrepancies (19 of the 116 individuals with intermediate or rapid genotype status having a slow phenotype). Further investigation showed that drinking coffee and not tea or cola was the most important factor for high levels of both metabolites. The concordance between phenotype and genotype status with regard to slow metabolism supported the recommendation of lower isoniazid doses in individuals with slow genotype status in order to avoid liver injury, a frequent side effect. The phenotypical variation observed for individuals with intermediate or rapid genotype status warrants further research before increased dosing of isoniazid can be recommended.


  • Maintaining a clinical weight loss after intensive lifestyle intervention is the key to cardiometabolic health

    by Sune Dandanell, Camilla Skovborg, Charlotte Boslev Præst, Kasper Bøgh Kristensen, Malene Glerup Nielsen, Sofie Lionett, Sofie Drevsholt Jørgensen, Andreas Vigelsø, Flemming Dela, Jørn Wulff Helge